The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy
Open accessAbstract
Osteoporosis associated with long-term glucocorticoid therapy remains a common and serious bone disease. Additionally, in recent years it has become clear that more subtle states of endogenous glucocorticoid excess may have a major impact on bone health. Adverse effects can be seen with mild systemic glucocorticoid excess, but there is also evidence of tissue-specific regulation of glucocorticoid action within bone as a mechanism of disease. This review article examines (1) the role of endogenous glucocorticoids in normal bone physiology, (2) the skeletal effects of endogenous glucocorticoid excess in the context of endocrine conditions such as Cushing disease/syndrome and autonomous cortisol secretion (subclinical Cushing syndrome), and (3) the actions of therapeutic (exogenous) glucocorticoids on bone. We review the extent to which the effect of glucocorticoids on bone is influenced by variations in tissue metabolizing enzymes and glucocorticoid receptor expression and sensitivity. We consider how the effects of therapeutic glucocorticoids on bone are complicated by the effects of the underlying inflammatory disease being treated. We also examine the impact that glucocorticoid replacement regimens have on bone in the context of primary and secondary adrenal insufficiency. We conclude that even subtle excess of endogenous or moderate doses of therapeutic glucocorticoids are detrimental to bone. However, in patients with inflammatory disorders there is a complex interplay between glucocorticoid treatment and underlying inflammation, with the underlying condition frequently representing the major component underpinning bone damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the deleterious effects of chronic glucocorticoid excess on bone mineral density leading to osteoporosis are well established (258).”
From Adrenal incidentaloma (2020) · cites this paper as [258]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–271 of 271
Hwang, J.-Y., Lee, S. H., Kim, G. S., Koh, J.-M., Go, M. J., Kim, Y.-J., Kim, H.-C., Kim, T.-H., Hong, J. M., Park, E. K., et al. (2009) · Bone · doi:10.1016/j.bone.2009.07.080 · Cited by 55
Chen, S.-J., Liao, W.-C., Huang, K., Lin, C., Tsai, W., Kung, P., Chang, K., & Kao, C. (2015) · QJM · doi:10.1093/qjmed/hcv012 · Cited by 55
Piemontese, M., Onal, M., Xiong, J., Wang, Y., Almeida, M., Thostenson, J. D., Weinstein, R. S., Manolagas, S. C., & O’Brien, C. A. (2015) · Bone · doi:10.1016/j.bone.2015.02.005 · Cited by 54
Kawamata, A., Iihara, M., Okamoto, T., & Obara, T. (2008) · World Journal of Surgery · doi:10.1007/s00268-007-9394-7 · Cited by 53
El‐Maouche, D., Collier, S., Prasad, M., Reynolds, J. C., & Merke, D. P. (2015) · Clinical Endocrinology · doi:10.1111/cen.12507 · Cited by 53
Gasparini, S. J., Weber, M.-C., Henneicke, H., Kim, S., Zhou, H., & Seibel, M. J. (2016) · Steroids · doi:10.1016/j.steroids.2016.10.008 · Cited by 52
Self-citationAssociation Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone
Axelsson, K. F., Nilsson, A. G., Wedel, H., Lundh, D., & Lorentzon, M. (2017) · JAMA · doi:10.1001/jama.2017.8040 · Cited by 52
Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells
Ahasan, M. M., Hardy, R., Jones, C. M., Kaur, K., Nanus, D. E., Juarez, M., Morgan, S., Hassan-Smith, Z. K., Bénézech, C., Caamaño, J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34414 · Cited by 50
Self-citationPrevalence of subclinical contributors to low bone mineral density and/or fragility fracture
Eller-Vainicher, C., Cairoli, E., Zhukouskaya, V. V., Morelli, V., Palmieri, S., Scillitani, A., Beck‐Peccoz, P., & Chiodini, I. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0102 · Cited by 49
Nuclear Receptor Function through Genomics: Lessons from the Glucocorticoid Receptor
Cohen, D. M., & Steger, D. J. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.04.001 · Cited by 49
Cooper, M. S., Syddall, H. E., Fall, C. H. D., Wood, P. J., Stewart, P. M., Cooper, C., & Dennison, E. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02281.x · Cited by 48
Shi, C., Huang, P., Kang, H., Hu, B., Qi, J., Jiang, M., Zhou, H., Guo, L., & Deng, L. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0314 · Cited by 47
Self-citationSilverman, S. L., Curtis, J. R., Saag, K. G., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2883-2 · Cited by 46
Skeletal energy homeostasis: a paradigm of endocrine discovery
Suchacki, K. J., Roberts, F. L., Lovdel, A., Farquharson, C., Morton, N. M., MacRae, V. E., & Cawthorn, W. P. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0147 · Cited by 46
Quax, R. A. M., Koper, J. W., HUISMAN, A. M., Weel, A. E. A. M., Hazes, J. M. W., Lamberts, S. W. J., & Feelders, R. A. (2015) · Rheumatology International · doi:10.1007/s00296-015-3235-z · Cited by 45
Szappanos, Á., Patócs, A., Tõke, J., Boyle, B., Sereg, M., Majnik, J., Borgulya, G., Varga, I., Likó, I., Rácz, K., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03528.x · Cited by 45
Osteoprotegerin Prevents Glucocorticoid-Induced Osteocyte Apoptosis in Mice
Weinstein, R. S., O’Brien, C. A., Almeida, M., Zhao, H., Roberson, P. K., Jilka, R. L., & Manolagas, S. C. (2011) · Endocrinology · doi:10.1210/en.2011-0170 · Cited by 44
Kung, A. W., Chan, T. M., Lau, C. S., Wong, R. W. S., & Yeung, S. S. C. (1999) · Rheumatology · doi:10.1093/rheumatology/38.12.1239 · Cited by 44
Optogenetic activation of Plexin-B1 reveals contact repulsion between osteoclasts and osteoblasts
Deb Roy, A., Yin, T., Choudhary, S., Rodionov, V., Pilbeam, C. C., & Wu, Y. I. (2017) · Nature Communications · doi:10.1038/ncomms15831 · Cited by 44
Ceccato, F., Barbot, M., Albiger, N., Zilio, M., De Toni, P., Luisetto, G., Zaninotto, M., Greggio, N. A., Boscaro, M., Scaroni, C., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0104 · Cited by 42
Fumoto, T., Ishii, K., Ito, M., Berger, S., Schütz, G., & Ikeda, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.149 · Cited by 41
Bone turnover in patients with endogenous Cushing’s syndrome before and after successful treatment
Szappanos, Á., Tõke, J., Lippai, D., Patócs, A., Igaz, P., Szücs, N., Fütő, L., Gláz, E., Rácz, K., & Tóth, M. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0978-y · Cited by 40
Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P. M., Ekman, B., Engström, B. E., Ragnarsson, Ó., Skrtic, S., Wahlberg, J., Achenbach, H., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0067 · Cited by 40
Strain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice
Ersek, A., Santo, A. I. E., Vattakuzhi, Y., George, S., Clark, A. R., & Horwood, N. J. (2016) · Scientific Reports · doi:10.1038/srep36513 · Cited by 39
Camozzi, V., Betterle, C., Frigo, A. C., Zaccariotto, V., Zaninotto, M., Caneva, E. D., Lucato, P., Gomiero, W., Garelli, S., Sabbadin, C., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1380-8 · Cited by 38
Hardy, R. S., Doig, C. L., Hussain, Z., O'Leary, M., Morgan, S. A., Pearson, M. J., Naylor, A., Jones, S. W., Filer, A., Stewart, P. M., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4806 · Cited by 37
Self-citationWoitge, H. W., Harrison, J. R., Ivkošić, A., Krozowski, Z. S., & Kream, B. E. (2001) · Endocrinology · doi:10.1210/endo.142.3.8044 · Cited by 36
Achiou, Z., Toumi, H., Touvier, J., Boudenot, A., Uzbekov, R. E., Ominsky, M. S., Pallu, S., & Lespessailles, É. (2015) · Bone · doi:10.1016/j.bone.2015.09.010 · Cited by 36
Camerino, C., Conte, E., Cannone, M., Caloiero, R., Fonzino, A., & Tricarico, D. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00456 · Cited by 36
Overman, R. A., Gourlay, M. L., Deal, C. L., Farley, J. F., Brookhart, M. A., & Layton, J. B. (2015) · Osteoporosis International · doi:10.1007/s00198-014-3022-9 · Cited by 34
Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas
Morelli, V., Eller-Vainicher, C., Palmieri, S., Cairoli, E., Salcuni, A. S., Scillitani, A., Carnevale, V., Corbetta, S., Arosio, M., Casa, S. D., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1423 · Cited by 34
van Schoor, N. M., Dennison, E. M., Lips, P. T. A. M., Uitterlinden, A. G., & Cooper, C. C. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02978.x · Cited by 33
ZHU, T. Y., Griffith, J. F., Qin, L., et al. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3077-2 · Cited by 33
Glucocorticoid Induced Osteoblast Apoptosis by Increasing E4BP4 Expression via Up-regulation of Bim
Chen, F., Zhang, L., Ouyang, Y., Guan, H., Liu, Q., & Ni, B. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9847-6 · Cited by 32
Yang, M., Trettel, L. B., Adams, D. J., Harrison, J. R., CANALIS, E. M., & Kream, B. E. (2010) · Bone · doi:10.1016/j.bone.2010.06.002 · Cited by 32
Sawamura, M., Komatsuda, A., Togashi, M., Wakui, H., & Takahashi, N. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7797 · Cited by 32
Myopathy in Addison's disease.
Mor, F., Green, P., & Wysenbeek, A. J. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.81 · Cited by 31
Prevention of glucocorticoid induced bone changes with beta-ecdysone
Dai, W., Jiang, L., Lay, Y.-A. E., Chen, H., Jin, G., Zhang, H., Kot, A., Ritchie, R. O., Lane, N. E., & Yao, W. (2015) · Bone · doi:10.1016/j.bone.2015.01.001 · Cited by 30
Siggelkow, H., Etmanski, M., Bozkurt, S., Groβ, P., Koepp, R., Brockmöller, J., & Tzvetkov, M. V. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1418 · Cited by 29
Tauchmanovà, L., Guerra, E., Pivonello, R., Martino, M. C. D., Leo, M. D., Caggiano, F., Lombardi, G., & Colao, A. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346473 · Cited by 28
Morimoto, E., Li, M., Khalid, A. B., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25399 · Cited by 27
Stimulation of 11β-HSD1 expression by IL-1β via a C/EBP binding site in human fetal lung fibroblasts
Yang, Z. H., Zhu, X.-O., Guo, C., & Sun, K. (2009) · Endocrine · doi:10.1007/s12020-009-9245-4 · Cited by 26
Ectopic Expression of Col2.3 and Col3.6 Promoters in the Brain and Association with Leptin Signaling
Scheller, E. L., Leinninger, G. M., Hankenson, K. D., Myers, M. G., & Krebsbach, P. H. (2011) · Cells Tissues Organs · doi:10.1159/000324745 · Cited by 26
Koetz, K., van Rossum, E. F. C., Ventz, M., Diederich, S., & Quinkler, M. O. (2012) · Clinical Endocrinology · doi:10.1111/cen.12096 · Cited by 26
Bone Mineral Density in Girls with Classical Congenital Adrenal Hyperplasia due to CYP21 Deficiency
Elnecave, R. H., Kopacek, C., Rigatto, M., Brenner, J. K., & de Castro, J. A. S. (2008) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2008.21.12.1155 · Cited by 26
Goddard, G. M., Ravikumar, A., & Levine, A. C. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.009 · Cited by 24
Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density
Grahnemo, L., Jochéms, C., Andersson, A., Engdahl, C., Ohlsson, C., Islander, U., & Carlsten, H. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0508 · Cited by 24
Feldman, K., Szappanos, Á., Butz, H., Grolmusz, V. K., Majnik, J., Likó, I., Kriszt, B., Lakatos, P. L., Tóth, M., Rácz, K., et al. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.014 · Cited by 23
Mazziotti, G., Maffezzoni, F., Doga, M., Hofbauer, L. C., Adler, R. A., & Giustina, A. (2014) · Bone · doi:10.1016/j.bone.2014.07.008 · Cited by 23
Glucocorticoid-Induced Osteoporosis ? A Disorder of Mesenchymal Stromal Cells?
Hardy, R., & Cooper, M. S. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00024 · Cited by 22
Self-citationOlsson, A., Oturai, D. B., Sørensen, P. S., Oturai, P., & Oturai, A. B. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514566417 · Cited by 22
Shi, L., Sánchez‐Guijo, A., Hartmann, M. F., Schönaü, E., Esche, J., Wudy, S. A., & Remer, T. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2347 · Cited by 21
Selective glucocorticoid receptor agonists: Glucocorticoid therapy with no regrets?
Cooper, M. S., Zhou, H., & Seibel, M. J. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1753 · Cited by 21
Self-citationEffects of glucocorticoids on calcium and phosphate excretion.
Ritz, E., Kreußer, W., & Rambausek, M. (1984) · PubMed · Cited by 21
Rodríguez, E. G., Lamy, O., Stoll, D., Metzger, M., Preisig, M., Kuehner, C., Vollenweider, P., Marques-Vidal, P. M., Waeber, G., Aubry‐Rozier, B., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3804 · Cited by 21
?-amyloid protein induces the formation of purine dimers in cellular DNA
Duker, N. J., Sperling, J. M., Soprano, K. J., Druin, D. P., Davis, A., & Ashworth, R. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010601)81:3 · Cited by 20
Ishiguro, S., Ito, K., Nakagawa, S., Hataji, O., & Sudo, A. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0336-1 · Cited by 18
Patel, P., Hardy, R., Sumathi, V. P., Bartle, G., Kindblom, L., Grimer, R. J., Bujalska, I. J., Stewart, P. M., Rabbitt, E. H., Gittoes, N. J. L., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0079 · Cited by 17
Self-citationBergman, J., Nordström, A., & Nordström, P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01912 · Cited by 17
Treatment of Juvenile Rheumatoid Arthritis with Growth Hormone
Simon, D., Prieur, A., & Czernichow, P. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053210 · Cited by 16
What is the optimal bone‐preserving strategy for patients with A ddison's disease?
Lee, P., & Greenfield, J. R. (2015) · Clinical Endocrinology · doi:10.1111/cen.12730 · Cited by 16
Diagnostic performance of osteocalcin measurements in patients with endogenous Cushing’s syndrome
Belaya, Z. E., Iljin, A. V., Mel'nichenko, G. A., Solodovnikov, A. G., Rozhinskaya, L. Y., Dzeranova, L. K., & Dedov, I. I. (2016) · BoneKEy Reports · doi:10.1038/bonekey.2016.42 · Cited by 16
Cooper, M. S., Kriel, M. H., Sayers, A. E., Fraser, W. D., Williams, A. M., Stewart, P. M., Probert, C. S., & Tobias, J. H. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9512-2 · Cited by 14
Self-citationHardy, R., Seibel, M. J., & Cooper, M. S. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.03.003 · Cited by 14
Self-citationSzappanos, Á., Patócs, A., Gergics, P., Bertalan, R. Á., Kerti, A., Ács, B., Feldman, K., Rácz, K., & Tóth, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.009 · Cited by 13
Management of Adrenal Incidentalomas
Terzolo, M., Reimondo, G., Bovio, S., Daffara, F., Allasino, B., Minetto, M. A., & Angeli, A. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-970408 · Cited by 12
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Griffiths, D. J., & Venables, P. J. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11 · Cited by 1
Glucocorticoid replacement therapy
Løvås, K. (2011) · 13th European Congress of Endocrinology · Cited by 1
Wilson (1999) · doi:10.1002/1529-0131(199907)42:7
Flagged first, then by citations
Cited by
Sorted by citations
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“Similarly, the deleterious effects of chronic glucocorticoid excess on bone mineral density leading to osteoporosis are well established (258).”
BackgroundMolecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people
Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01817-y · Cited by 199
Pathogenic mechanisms of glucocorticoid-induced osteoporosis
Chen, M., Fu, W., Xu, H., & Liu, C.-J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.03.002 · Cited by 146
Anastasilakis, A. D., Tsourdi, E., Makras, P., Polyzos, S. A., Meier, C., McCloskey, E. V., Pepe, J., & Zillikens, M. C. (2019) · Bone · doi:10.1016/j.bone.2019.07.006 · Cited by 71
Metadata
- Authors
- Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S.
- Affiliations
- University of Birmingham (GB)
- Anzac Research Institute (AU)
- The University of Sydney (AU)
- Corresponding author
- Cooper, Mark S
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2018-06-13
- Volume
- 39
- Issue
- 5
- Pages
- 519-548
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2808631980
- Cited by
- 258
- References
- 271
- Citations by year
- 2026: 28 · 2025: 32 · 2024: 34 · 2023: 46 · 2022: 35 · 2021: 33 · 2020: 31 · 2019: 14 · 2018: 5
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- Versus Arthritis (20843)
- Medical Research Council (MR/P021220/1)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoids, bone health, glucocorticoid-induced osteoporosis, Cushing's disease, subclinical Cushing's syndrome, autonomous cortisol secretion, glucocorticoid replacement therapy, adrenal insufficiency, glucocorticoid receptor, bone metabolism, inflammatory diseases, glucocorticoid metabolism
- MeSH terms
- Cushing Syndrome, Glucocorticoids, Humans, Osteoporosis, Bone Density, Hormone Replacement Therapy, Pituitary ACTH Hypersecretion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
